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1. Introduction 
The discovery of Ca2+-activatable phosphodiester- 
ase [l] led to the discovery of the modulator protein 
which confers the Ca’+-sensitivity upon this enzyme 
[2,3]. An activator of phosphodiesterase was indepen- 
dently reported. The identity of both proteins was 
established subsequently [5]. This modulator protein 
nowadays termed calmodulin exhibits the Ca2+-depen- 
dent activation of a number of enzymes and is now 
regarded as an intracellular mediator of actions of 
Ca2+ [6]. Its ubiquitous distribution in the animal and 
plant kingdoms and its structural and functional con- 
servativeness throughout molecular evolution are well 
established [6,7]. 
Although there is general agreement concerning 
the gross similarities among vertebrate calmodulins, 
minor differences in structure and mobility upon 
polyacrylamide gel electrophoresis were seen between 
calmodulin preparations from rat testis [ 81, bovine 
uterus [9] and bovine brain [ 10,111. It is thought 
that these differences are rather artifactual or due to 
mistaken assignments of the amino acid sequence, but 
this has not yet been proved or disproved. The pres- 
ent study supports the proposal that there is no dif- 
ference between calmodulins from different tissues. It 
also describes a convenient purification method 
calmodulin giving an overall recovery of >70%. 
for 
Abbreviations: PMSF, phenylmethyl-sulfonylfluoride; 1 FOY, 
(ethyl-p’-(6’-guanidinohexanoyloxy)benzoatej methane sul- 
fonate; EGTA, ethyleneglycol bis(p-aminoethylether)-N,N’- 
tetraacetic acid; EDTA, ethylenediamine tetraacetic acid 
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2. Materials and methods 
2.1. Materials 
PMSF and DFP were from Sigma Chemicals 
(St Louis MO). Leupeptin, pepstatin A, antipain were 
from the Peptide Institute (Osaka). Epoxy-activated 
Sepharose 6B was from Pharmacia (Japan). Fluphen- 
azine maleate and FOY were generous gifts of the 
Yoshitomi and Ono Pharmaceutical companies, 
respectively. 
2.2. Preparation of jluphenazine-Sepharose 
Epoxy-activated Sepharose 6B was soaked with 
deionized water and then washed with a coupling 
reaction medium consisting of 0.1 M carbonate buffer 
(pH 11) and dioxane at 20% (v/v) final cont. Washed 
epoxy-activated Sepharose (5 ml) was incubated for 
48 h at 50°C in the above reaction medium contain- 
ing 400 mg fluphenazine maleate in 20 ml and final 
pH 11: pH was readjusted by the addition of NaOH. 
The incubation was carried out in an incubator with 
shaking. At the end of the incubation, the Sepharose 
slurry was washed on a sintered glass funnel with the 
reaction medium and then with deionized water. It 
was then suspended in 2-3 resin volumes of 1 M 
ethanolamine (PH S.O), followed by filtration on a 
sintered glass funnel. This procedure was repeated 
several times and the total incubation time with 
ethanolamine was >2 h. The ethanolamine-treated 
Sepharose was washed with deionized water and then 
with 20 mM Tris-HCl (pH 7.5) on a sintered glass 
funnel. Care was taken to minimize the exposure to 
light of the fluphenazine-coupled Sepharose during the 
coupling reaction and subsequent storage. 
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2.3. Purification of platelet calmodulin 
Fresh bovine blood containing 1110th vol. 5% dex- 
trose solution-77 mM EDTA to prevent coagulation 
was centrifuged at 250 X g for 10 min. The resultant 
supernatant (platelet rich plasma) was then centri- 
fuged at 1500 X g for 5 min. The pellet was resus- 
pended in Ca’+- and glucose-free Tyrode’s solution 
containing 1 mM EGTA. The suspension was recentri- 
fuged as above. This washing procedure was repeated 
twice and final pellet was resuspended in 20 mM 
Tris-HCl (PH 7.4) 1 mM EGTA, 150 mM NaCI, 
0.5 mM FOY, 1 mM PMSF, pepstatin A (0.1 pg/ml), 
antipain (5 pg/ml). This mixture was kept frozen at 
-80°C until use. The frozen pellet of platelets 
(30 ml) was homogenized with 3 vol. (90 ml) 4.0% 
(w/v) trichloroacetic acid. After 20 min gentle stir- 
ring, the mixture was centrifuged at 20 000 X g for 
30 min. The resultant pellet was homogenized with 
125 ml medium A consisting of 20 mM Tris--HCl 
(pH 7.5) 5 mM EDTA, 0.1 mM diisopropylfluoro- 
phosphate, pepstatin A (0.05 pg/ml) and antipain 
(2 pg/ml). The pH of this homogenate was adjusted 
to 7.5 by the dropwise addition of 6 M NaOH and 
the homogenate was centrifuged at 105 000 X g for 
60 mm. The pellet was rehomogenized with 30 ml 
medium A and recentrifuged as above. The super- 
natant fluids derived from these 2 homogenates 
(120 ml, 27 ml) were combined and applied to a col- 
umn (1.5 X 11 .S cm) of DEAE-cellulose which had 
been equilibrated with 20 mM Tris-HCl (pH 7.5) 
5 mM 2-mercaptoethanol, 0.1 mM EGTA (medium B). 
The column was eluted with medium B plus 0.145 M 
(NH4)2S04 (at I +) and then with medium B plus 
0.3 M (NH4)*S04 (at II +) (tig.3a). Fractions of 4 ml 
each were collected. Fractions containing calmodulin 
activity were combined (tubes no. 106-l 12) and 
diluted with an equal volume of 20 mM Tris-HCl 
(PH 7.5) 5 mM 2-mercaptoethanol and 0.5 mM CaCl* 
to make 0.15 M in (NH4)*S04 and 0.2 mM in free 
Ca’+. The diluted solution was applied to a column 
(0.8 X 1.2 cm) of the fluphenazine-Sepharose 6B. 
The column, which had been equilibrated with 
20 mM Tris-HCl (pH 7.5) 5 mM 2-mercaptoethanol, 
500 mM NaCl and 0.2 mM CaC12, was eluted with 
the above wash medium. At arrow III, the elution 
medium was switched to 20 mM Tris-HCl (pH 7.5) 
5 mM 2-mercaptoethanol, 500 mM NaCl and 2 mM 
EGTA (fig.3b). Fractions of 4 ml each (tubes 
no. l-35) or 1 ml each (tubes no. 36-) were col- 
lected. Fractions containing calmodulin were com- 
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bined (tubes no. 3640) and saved. The above proce- 
dures were done at 4°C. 
2.4. Purification oj’calmodulirz from other sources 
Fresh bovine brain and testis were obtained from a 
local slaughterhouse. A thermotolerant strain of 
Tetrahymena pytiformis (NH-I) was kindly provided 
by Dr Y. Nozawa, Gifu University. The cells collected 
by centrifugation were frozen in dry ice and trans- 
ported to the laboratory in dry ice. These materials 
were homogenized in Waring Blendor with 3 vol. 
4.0% trichloroacetic acid. With the frozen samples 
trichloroacetic acid was added while the samples were 
still frozen, this addition being immediately followed 
by the homogenization. Calmodulin was purified 
from these homogenates by essentially those proce- 
dures described for platelet, except that medium A 
was altered to 20 mM Tris-HCl (pH 7.5) 5 mM 
EDTA, 0.1 mM diisopropylfluorophosphate, pepsta- 
tin A (0.05 pg/ml), and PMSF (50 pg/ml). For Tetra- 
hymena samples, final concentrations of diisopropyl- 
fluorophosphate and pepstatin A were 1 mM and 
0.5 pg/ml, respectively. 
2.5. Analytical procedures 
Calmodulin was determined according to its ability 
to activate the calmodulin-deficient brain phospho- 
diesterase [121. Values were corrected as in [ 131. 
Protein was determined as in [ 131. Electrophoresis of 
proteins was done in 15% polyacrylamide gels in the 
buffer system of Davis [ 141 (50 mM Tris-384 mM 
glycine, pH 8.3), or in 0.1% SDS in a Iaemmli buffer 
system [ 151. When system of Davis was employed, 
either EGTA or CaCl, was added to both the gels and 
the samples at 0.2 mM final cont. 
3. Results and discussion 
These studies were undertaken to determine 
whether calmodulin preparations from different tis- 
sues of the same species (bovine) were identical. Cal- 
modulins were purified to homogeneity from bovine 
platelet, testis and brain as judged by polyacrylamide 
gel electrophoresis in three different conditions, i.e., 
in SDS gel and in non-denaturing gels in the presence 
and absence (+EGTA) of Ca*+ (fig.1 a,b). Calmodulin 
showed a characteristic mobility change on non- 
denaturing gels depending upon the presence and 
absence of Ca*+ in the gels. The decreased mobility of 
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Fig.1. Comparison of calmodulins upon polyacrylamide gel 
electrophoresis. (a) Results with platelet and brain proteins 
using the buffer system of Davis [ 141 containing either 
0.2 mM CaCl, (l-3) or EGTA (4-6): (1,4) 2 pg of platelet 
protein; (2,5) 2 pg brain protein; (3,6) 1 fig each of both pro- 
teins. Identical results were obtained with testis and brain 
proteins (not shown). (b) Results with testis and brain pro- 
teins using a buffer system of Laemmli [15] containing 0.1% 
SDS: (1) 2.5 pg brain protein; (2) 2.5 pg testis protein; (3) 
2.5 pg each of both proteins. Identical results were obtained 
with platelet and brain proteins (not shown). 
calmodulin in the presence of Ca’+ contrasts with the 
increased mobility of troponin C [ 161 and leiotonin C 
[ 171 and also with the mobility of the majority of 
other cellular proteins which are unaffected by Ca*+. 
Therefore, polyacrylamide gel electrophoresis can be 
used as a reliable identification method for calmodu- 
lin [ 121. It also acts as a sensitive purity check of cal- 
modulin. Calmodulin preparations from platelet and 
testis coincided with brain calmodulin in each of the 
3 different electrophoretic systems (fig.la,b). In [8] 
rat testis calmodulin and bovine brain calmodulin 
separated into two distinct bands on SDS gel electro- 
phoresis. The reason for this discrepancy is not clear 
at present. 
Another criterion for the identification of cal- 
modulin is its ability to activate phosphodiesterase. 
Calmodulin preparations of platelet, testis and brain 
were indistinguishable in their Ca*+-dependent activa- 
tion of the calmodulin-deficient brain phosphodiester- 
ase activity (fig.2). Thus, the results are consistent 
with the proposal that there is no tissue difference of 
calmodulin. 
With the purification method used here, yields of 
calmodulins from bovine platelet, brain and Tetru- 
hymena were 49,200 and 70 ~g, respectively, per ml 
cells (platelet and Tetrahymena) or per g tissue 
(brain). Since we determined the calmodulin content 
of these cells to be -60,300 and 100 ~g, respec- 
tively, per ml or g, above yield values represent the 
recovery rate of -70% for all cases, the highest rate 
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Fig.2. Ca’+-dependent activation of the calmodulindeficient 
brain phosphodiesterase activity by platelet (0) and brain (0) 
calmodulins. In (a), calmodulin was 0.35 pg/assay tube 
(0.5 ml). Ca”-EGTA mixture was used to produce the indi- 
cated concentrations of free Ca’+ [ 121. In (b), all assay tubes 
contained 0.1 mM CaCl,. 
ever reported. Although there are a variety of pub- 
lished methods for the purification of calmodulin, 
most are time-consuming and give low recoveries. The 
phenothiazine affinity chromatography developed in 
[ 18,191 is certainly superior to the other methods in its 
simplicity. However, there was only a slight improve- 
ment in its overall recovery as compared to other 
methods. The purification method used here is there- 
fore described in detail in sections 3.1-3.3; the 3 step 
procedure can be accomplished within 3 days. Appli- 
cation of this method to bovine platelet is summa- 
rized in table 1. 
3 .I. Trichloroacetic acid treatment 
It was essential to guard against the proteolytic 
attack on calmodulin during the initial homogeniza- 
tion and subsequent procedures, because some of the 
proteolytic products of calmodulin behaved like cal- 
modulin upon column chromatography and were 
poorly separated from the latter. Attempts to destroy 
the proteolytic activity by heat-treatment of homoge- 
nates often resulted in the increased production of 
the proteolytic fragments. During the initial rise in 
temperature an activated proteolysis may have taken 
place. Making the homogenate with trichloroacetic 
acid and inclusion of protease inhibitors in the sub- 
sequent step gave a satisfactory result. The trichloro- 
acetic acid treatment from [20] was modified so that 
the recovery at this step was -80%. 
3.2. DEAE-cellulose column chromatography 
After the sample application, the column was 
washed by a medium containing 0.145 M (NH4)2SO+ 
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Table 1 
Summary of purification of calmodulin from bovine platelets 
Protein Calmodulin Yield 
(mg) (%) 
(fig/mg protein) G.4 
Homogenate 10s9a 1.8 1960a 100 
Trichloroacetic acid 
supernatant 35 n.d. b n.d. _ 
Trichloroacetic acid 
precipitate 1005 1.5 1507 77 
Extract from the trichloro- 
acetic acid precipitate 145 10 1450 14 
Residue after the above 
extraction 851 n.d. n.d. _ 
DEAE-cellulose column 18 81 1458 14 
Fluphenazine-Sepharose 
column 1.4 1040 1456 74 
a Derived from 30 ml packed volume; therefore, calmodulin in the original 
b 
homogenate was 63 pg/ml packed volume 
n.d., not detectable 
Many proteins were eluted from the column by this 
wash. Calmodulin was then eluted from the column 
by raising the concentration of (NH4)*S04 to 0.3 M 
(fig.3a). This 2-step elution instead of a gradient 
elution made the chromatography operation quite 
simple. 
3.3. Fluphenazine affinity chromatography 
The recovery of this step increased to -100% 
(with brain sample) as compared to 55% with the 
original method [ 181. We found that 2 factors are 
important in the high recovery: 
(i) The calmodulin-binding proteins [21,22] inter- 
fere with the Ca’+-dependent binding of the cal- 
modulin to the resin. Here, the sample after the 
FRACTION NUMBER FRACTION NUMBER 
Fig.3. Purification of platelet calmodulin by column chro- 
matographies. DEAE-cellulose column chromatography (a), 
and fluphenazine affinity chromatography (b) were done as 
in the text. 
DEAE-cellulose column was devoid of such activ- 
ity. The binding proteins must have been removed 
by the preceding procedures. 
(ii) More importantly, the Sepharose matrix, though 
treated with ethanolamine, bound calmodulin 
non-specifically and irreversibly. Thus, the recov- 
ery decreased as the amount of calmodulin 
applied to the resin column was decreased 
(table 2). The degree of such non-specific binding 
of calmodulin was greater with the Sepharose 
which was not treated with phenothiazine than 
Table 2 
Recovery of calmodulin upon fluphenazine affinity 
chromatography 
Expt Calmodulin applied Calmodulin recovered 
no. 
(fig) (% of the total 
column capacity) 
(pg) (% recovery) 
1 31 2.7 25 80 
2 360 32 330 92 
3 690 60 680 99 
Various amounts of brain sample after DEAE-cellulose col- 
umn, containing 91 fig/ml calmodulin, was applied to a 
0.25 ml fluphenaztie-Sepharose column (6 mm diam.). In a 
separate experiment, the total capacity of the column was 
calibrated to be 1 .I 5 mg calmodulin. Calmodulin was deter- 
mined according to its ability to activate brain phosphodi- 
esterase (see section 2) 
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with the Sepharose treated with phenothiazine, 
since we observed that the recovery of calmodu- 
lin from a column containing a mixture of 1 part 
of fluphenazine-Sepharose and 3 parts of etha- 
nolamine-treated Sepharose was 60% when the 
column was loaded with an amount of calmodu- 
lin corresponding to half the total column 
capacity. 
On the basis of these observations, we modified the 
procedure of the affinity chromatography as follows: 
(a) The amount of the calmodulin sample applied to 
the column was adjusted to at least 1/3rd of the 
capacity of the column; 
(b) A large excess of fluphenazine was used for the 
coupling reaction when fluphenazine-Sepharose 
was synthesized. 
The latter resulted in the increased capacity of the gel 
for calmodulin-binding compared to the original 
method [ 181 (4.6 mg us 3 mg calmodulin/ml gel) and 
contributed to the decrease of the non-specific cal- 
mod&n-binding of the resin matrix. A typical elution 
profile of the affinity chromatography is shown in 
fig3b. Tetrahymena calmodulin is slightly different 
from the mammalian protein [I 3 1, but it was eluted 
from the columns in exactly the same manner as the 
mammalian calmodulin. 
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